Loading...

Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 63.89 USD +1.72% Market Closed
Updated: Dec 6, 2022

Intrinsic Value

The intrinsic value of one PBH stock under the Base Case scenario is 69.59 USD. Compared to the current market price of 63.89 USD, Prestige Consumer Healthcare Inc is Undervalued by 8%.

The Intrinsic Value is calculated as the average of the two valuation methods:

PBH Intrinsic Value
Base Case
69.59 USD
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

PBH Profitability Score
Profitability Due Diligence

Prestige Consumer Healthcare Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive ROIC
Declining ROIC
Positive 3-Year Average ROE
61/100
Profitability
Score

Prestige Consumer Healthcare Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

PBH Solvency Score
Solvency Due Diligence

Prestige Consumer Healthcare Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Average Interest Coverage
Average Altman Z-Score
Low D/E
40/100
Solvency
Score

Prestige Consumer Healthcare Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
56%
Gross Margin
30%
Operating Margin
19%
Net Margin
22%
FCF Margin
14%
ROE
7%
ROIC
Other

PBH Capital Structure
Prestige Consumer Healthcare Inc

Market Capitalization 3.2B USD
Total Debt 1.4B USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 42.4M USD
Short-Term Investments 0 USD
Enterprise Value 4.6B USD

Wall St
Price Targets

PBH Price Targets Summary
Prestige Consumer Healthcare Inc

Wall Street analysts forecast PBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBH is 67.83 USD with a low forecast of 60.6 USD and a high forecast of 75.6 USD.

Lowest
Price Target
60.6 USD
5% Downside
Average
Price Target
67.83 USD
6% Upside
Highest
Price Target
75.6 USD
18% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

PBH Competitors
Prestige Consumer Healthcare Inc

PBH Suppliers & Customers
Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc has 1 key suppliers from 1 countries and 1 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Retail industry.

United States of America
1
Suppliers Map

Prestige Consumer Healthcare Inc has 3 key customers from 2 countries and 1 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Retail industry.

Customers Map

Ownership

PBH Insider Trading
Buy and sell transactions by insiders

Prestige Consumer Healthcare Inc insiders have only sold shares in the past 12 months.

During the last 12 months Prestige Consumer Healthcare Inc insiders have not bought any shares, and sold 2.7M USD worth of shares. The last transaction was made on Dec 6, 2022 by Fritz Mary Beth (SVP Quality & Regulatory), who sold 438k USD worth of PBH shares.

Sold
0-3
months
2.7M USD
2
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
2.7M USD
N/A
-2.7M
6 Months
2.7M USD
N/A
-2.7M
9 Months
2.7M USD
N/A
-2.7M
12 Months
2.7M USD
N/A
-2.7M
Purchases
25
Sales
149
Why is insider trading important?

Shareholder Return

PBH Price
Prestige Consumer Healthcare Inc

1M 1M
+12%
6M 6M
+13%
1Y 1Y
+10%
3Y 3Y
+67%
5Y 5Y
+38%
Annual Price Range
63.89
52w Low
48.72
52w High
63.89
Price Metrics
Average Annual Return -3.58%
Standard Deviation of Annual Returns 25.6%
Max Drawdown -42%
Shares Statistics
Market Capitalization 3.2B USD
Shares Outstanding 49 762 600
Percentage of Shares Shorted 3.08%

Company Profile

Prestige Consumer Healthcare Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

3.2B USD

Dividend Yield

0%

Description

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 505 full-time employees. The company went IPO on 2005-02-10. The firm operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.

Contact

NEW YORK
Tarrytown
660 White Plains Rd
+19145246800.0
http://prestigebrands.com

IPO

2005-02-10

Employees

505

Officers

Chairman, Pres & CEO
Mr. Ronald M. Lombardi
Chief Financial Officer
Ms. Christine Sacco
Sr. VP of Operations
Mr. Jeffrey Zerillo
Sr. VP, Gen. Counsel & Corp. Sec.
Mr. William C. P'Pool
Exec. VP of Marketing & Sales
Mr. Adel Mekhail
Director of Investor Relations
Mr. Philip David Terpolilli
Show More
Director of Communications
Dean Siegal
Sr. VP of Quality & Regulatory Affairs
Ms. Mary Beth Fritz
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one PBH stock?

The intrinsic value of one PBH stock under the Base Case scenario is 69.59 USD.

Is PBH stock undervalued or overvalued?

Compared to the current market price of 63.89 USD, Prestige Consumer Healthcare Inc is Undervalued by 8%.